ZA981034B - Formulation of stabilized cationic transfection agent(s)/nucleic acid particles - Google Patents

Formulation of stabilized cationic transfection agent(s)/nucleic acid particles

Info

Publication number
ZA981034B
ZA981034B ZA981034A ZA981034A ZA981034B ZA 981034 B ZA981034 B ZA 981034B ZA 981034 A ZA981034 A ZA 981034A ZA 981034 A ZA981034 A ZA 981034A ZA 981034 B ZA981034 B ZA 981034B
Authority
ZA
South Africa
Prior art keywords
nucleic acid
transfection agent
formulation
acid particles
cationic transfection
Prior art date
Application number
ZA981034A
Other languages
English (en)
Inventor
Joel Crouzet
Bruno Pitard
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9503492&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA981034(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA981034B publication Critical patent/ZA981034B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
ZA981034A 1997-02-10 1998-02-09 Formulation of stabilized cationic transfection agent(s)/nucleic acid particles ZA981034B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9701467A FR2759298B1 (fr) 1997-02-10 1997-02-10 Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees

Publications (1)

Publication Number Publication Date
ZA981034B true ZA981034B (en) 1998-08-11

Family

ID=9503492

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA981034A ZA981034B (en) 1997-02-10 1998-02-09 Formulation of stabilized cationic transfection agent(s)/nucleic acid particles

Country Status (20)

Country Link
EP (1) EP1007097B1 (ko)
JP (1) JP2001511171A (ko)
KR (1) KR20000070914A (ko)
AT (1) ATE206932T1 (ko)
AU (1) AU737720B2 (ko)
BR (1) BR9807563A (ko)
CA (1) CA2278665A1 (ko)
CZ (1) CZ282199A3 (ko)
DE (1) DE69802102T2 (ko)
DK (1) DK1007097T3 (ko)
ES (1) ES2166146T3 (ko)
FR (1) FR2759298B1 (ko)
GR (1) GR3036919T3 (ko)
HU (1) HUP0001720A3 (ko)
IL (1) IL130765A0 (ko)
NO (1) NO993825L (ko)
PT (1) PT1007097E (ko)
SK (1) SK282685B6 (ko)
WO (1) WO1998034648A1 (ko)
ZA (1) ZA981034B (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6359054B1 (en) * 1994-11-18 2002-03-19 Supratek Pharma Inc. Polynucleotide compositions for intramuscular administration
AU768542C (en) * 1998-04-08 2004-06-17 Celltech R & D Limited Lipids
CA2335393C (en) * 1998-07-20 2008-09-23 Inex Pharmaceuticals Corporation Liposomal encapsulated nucleic acid-complexes
EP1309904A4 (en) * 2000-03-03 2006-03-29 Valentis Inc IMPROVED POLOXAMER AND POLYOAMINE COMPOUNDS FOR NUCLEINE SUCTION INTRODUCTION
GB0009201D0 (en) * 2000-04-14 2000-05-31 Univ Nottingham Cationic polymer - Nucleic acid complexes and methods of making them
US20020091242A1 (en) 2000-10-11 2002-07-11 Michel Bessodes Acid-sensitive compounds, their preparation and uses
CA2426582A1 (en) * 2000-10-20 2002-08-08 Valentis, Inc. Gene delivery formulations and methods for treatment of ischemic conditions
EP1232758A1 (fr) * 2001-02-19 2002-08-21 Aventis Pasteur Polynucléotide formulé en vue d'un transfert intracellulaire amélioré
WO2005120546A2 (en) * 2004-03-03 2005-12-22 Essentia Biosystems, Inc. Compositions and methods for topical diagnostic and therapeutic transport
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
JP2008531732A (ja) 2005-03-03 2008-08-14 ルバンス セラピュティックス インク. ボツリヌス毒素の局所塗布及び経皮送達のための組成物及び方法
JP4653242B1 (ja) 2010-02-12 2011-03-16 ナノキャリア株式会社 粒子状医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1181937A3 (en) * 1994-08-09 2004-02-04 Cytrx Corporation Novel vaccine adjuvant and vaccine
AU5527696A (en) * 1995-03-31 1996-10-16 Children's Hospital Medical Center Use of surfactants for introducing genetic material into lun g cells
US6120794A (en) * 1995-09-26 2000-09-19 University Of Pittsburgh Emulsion and micellar formulations for the delivery of biologically active substances to cells

Also Published As

Publication number Publication date
DE69802102D1 (de) 2001-11-22
HUP0001720A3 (en) 2001-10-29
BR9807563A (pt) 2000-02-01
HUP0001720A1 (hu) 2000-09-28
CA2278665A1 (fr) 1998-08-13
CZ282199A3 (cs) 1999-10-13
SK108299A3 (en) 2000-05-16
KR20000070914A (ko) 2000-11-25
ES2166146T3 (es) 2002-04-01
DK1007097T3 (da) 2002-02-11
FR2759298A1 (fr) 1998-08-14
PT1007097E (pt) 2002-04-29
NO993825D0 (no) 1999-08-09
EP1007097A1 (fr) 2000-06-14
GR3036919T3 (en) 2002-01-31
AU6298798A (en) 1998-08-26
JP2001511171A (ja) 2001-08-07
WO1998034648A1 (fr) 1998-08-13
ATE206932T1 (de) 2001-11-15
DE69802102T2 (de) 2002-03-14
IL130765A0 (en) 2001-01-28
NO993825L (no) 1999-08-09
EP1007097B1 (fr) 2001-10-17
SK282685B6 (sk) 2002-11-06
FR2759298B1 (fr) 1999-04-09
AU737720B2 (en) 2001-08-30

Similar Documents

Publication Publication Date Title
ZA981034B (en) Formulation of stabilized cationic transfection agent(s)/nucleic acid particles
HK1017995A1 (en) Compounds and compositions for delivering active agents.
EP0911039A3 (en) Drug-resin complexes stabilized by chelating agents
IL115742A0 (en) Pharmaceutical compositions comprising a difficultly soluble active agent
EP1135173A4 (en) MEDICINAL AEROSOL FORMULATION
IL172835A0 (en) A composition for stabilizing active protein ingredients in pharmaceutical composition containing at least 2 amino acids
HK1028548A1 (en) Formulations for hydrophobic pharmaceutical agents
HK1097777A1 (en) Medicinal aerosol formulation
GR3036440T3 (en) Personal care compositions and wipe products containing the compositions
ZA98792B (en) Bar compositions comprising adjuvant powders for delivering benefit agent and process for the manufacture of said bars.
WO2000032186A3 (en) Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
CA2194979A1 (en) Solid drug forms containing clathrates of steroid sex hormones
WO2000050046A8 (en) Stabilized oral pharmaceutical composition containing iodide and iodate and method
AU3868997A (en) Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
AU1869601A (en) Pharmaceutical compositions comprising trimegestone
RO117500B1 (ro) Compoziţie cosmetică
BR9811985A (pt) Dispositivo de dosagem
WO1998023260A3 (en) Non-ionic surfactant vesicles as a delivery agent for nucleic acid
WO2001006963A3 (en) Orthopaedic bone cement mixing container
WO1998023297A3 (en) Particulate compositions
EP0891778A3 (en) Agents for the prevention and/or treatment of radiation-induced disorders
Gorshkov et al. Effects of Nitrogen-Containing Compounds on H sub 2 PtCl sub 6 Activity in Hydrosilication of Unsaturated Siloxane Rubbers
MX9708160A (es) Composicion y aparato para la limpieza de superficies.
MX9603741A (es) Composicion de liberacion mantenida.
SI1007097T1 (en) Formulation of stabilised cationic transfection agent(s)/nucleic acid particles